Management of Unsuppressed Menstrual Cycle

Initial Assessment

The American College of Obstetricians and Gynecologists recommends ruling out underlying gynecological problems such as pregnancy, STDs, medication interactions, or pathologic uterine conditions before starting treatment 2, 1
Determining the pattern and severity of bleeding is crucial to guide appropriate management, according to the Centers for Disease Control and Prevention 2

For mild to moderate bleeding, the American College of Obstetricians and Gynecologists suggests using NSAIDs for 5-7 days during days of bleeding, which reduces blood flow without hormonal intervention 2, 1
For heavy or prolonged bleeding, the Centers for Disease Control and Prevention recommends short-term treatment with low-dose combined oral contraceptives containing 30-35 μg ethinyl estradiol for 10-20 days, which helps stabilize the endometrium and reduce bleeding 2, 1

For combined hormonal contraceptive users with unscheduled bleeding, the Centers for Disease Control and Prevention suggests considering a 3-4 day hormone-free interval, but not during the first 21 days of using continuous or extended combined hormonal contraceptives 3
For patients using DMPA with unscheduled bleeding, the Centers for Disease Control and Prevention recommends using NSAIDs for 5-7 days during days of bleeding 2
If one hormonal pill is late (<24 hours), the Centers for Disease Control and Prevention advises taking the missed pill as soon as possible and continuing the regular schedule 5
If two or more consecutive pills have been missed (≥48 hours), the Centers for Disease Control and Prevention recommends taking the most recent missed pill immediately, continuing the remaining pills at the usual time, and using backup contraception for 7 consecutive days 5

Enhanced counseling about expected bleeding patterns can reduce method discontinuation, according to the Centers for Disease Control and Prevention 4, 1
For patients using extended or continuous combined hormonal contraceptives, unscheduled spotting or bleeding is common during the first 3-6 months and generally decreases with continued use, as noted by the Centers for Disease Control and Prevention 3
Amenorrhea does not require medical treatment and can be managed with reassurance, though if unacceptable to the patient, alternative contraceptive methods should be considered, according to the Centers for Disease Control and Prevention 2

The use of combined hormonal contraceptives for managing bleeding increases the risk of venous thromboembolism three to fourfold, as reported by the American College of Obstetricians and Gynecologists 1